CERT - Certara, Inc.

7.35
0.110   1.497%

Share volume: 4,787,214
Last Updated: 03-04-2026
Computer Software/Services – Computer Programming And Data Processing: -0.16%

PREVIOUS CLOSE
CHG
CHG%
$7.24
0.11
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 38%
Dept financing 35%
Liquidity 58%
Performance 31%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.26%
1 Month
-0.41%
3 Months
-20.28%
6 Months
-30.13%
1 Year
-38.29%
2 Year
-60.51%
Key data
Stock price
$7.35
P/E Ratio 
0.00
DAY RANGE
$7.24 - $7.48
EPS 
$0.04
52 WEEK RANGE
$6.04 - $15.38
52 WEEK CHANGE
-$36.75
MARKET CAP 
1.403 B
YIELD 
N/A
SHARES OUTSTANDING 
159.140 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
1.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,892,350
AVERAGE 30 VOLUME 
$3,555,191
Company detail
CEO: William F. Feehery
Region: US
Website: certara.com
Employees: 350
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Recent news